They can be performed on cancer cells to identify genes that confer resistance to T cell-mediated killing (3, 4), upregulate MHC class I molecules without upregulating PD-L1 (5) or downregulate immunosuppressive CD47 (6). The gene discussed is CD274; the disease is cancer.